Welcome to ATMP Sweden

ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.

Learn about membership

CGT Sweden

Establishing a sustainable national coordination function for Advanced Therapies that strengthens regional centres, supports clinical research, ensures equitable patient access to treatment, and facilitates translation into development and manufacturing.

Learn more

What are ATMPs?

Advanced Therapy Medicinal Products (ATMPs) are a new generation of medicines based on genes, cells, or engineered tissues that can repair, replace, or modify biological functions in the body. These innovative therapies are transforming how diseases can be treated, and sometimes even cured – creating new possibilities for patients with conditions that previously had limited treatment options.

Learn more
News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Receives CTA Approval for Phase II/III Study of P-TEV 13 May 2026 NHTA NICE approves givinostat for Duchenne muscular dystrophy 8 May 2026 NHTA TLV to host seminar on U.S. MFN policy 8 May 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q1 2026 – Continued Clinical Progress 7 May 2026 Testa Center Testa Center 2024 6 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 Alla nyheter Gemensam informationsstruktur ska stärka kliniska prövningar i Sverige 31 March 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 Testa Center Testa Center Access Grant 25 March 2026 DBMD När delaktighet skapar livskvalitet: Möt Loa Strandvik 25 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 PHI Phase Holographic Imaging PHI AB Announces Intent to File for Bankruptcy 12 January 2026 PHI Interim Report 2 2025/26 19 December 2025 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 OptiCell Solutions OptiCell Solutions enters into new collaboration 2 December 2025 ATMP Flemingsberg OptiCell Solutions enters a research collaboration with Karolinska Institutet 11 November 2025 DBMD Välkommen att ansöka till familjevistelsen om Duchennes muskeldystrofi! 5 November 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Receives CTA Approval for Phase II/III Study of P-TEV 13 May 2026 NHTA NICE approves givinostat for Duchenne muscular dystrophy 8 May 2026 NHTA TLV to host seminar on U.S. MFN policy 8 May 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q1 2026 – Continued Clinical Progress 7 May 2026 Testa Center Testa Center 2024 6 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 Alla nyheter Gemensam informationsstruktur ska stärka kliniska prövningar i Sverige 31 March 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 Testa Center Testa Center Access Grant 25 March 2026 DBMD När delaktighet skapar livskvalitet: Möt Loa Strandvik 25 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 PHI Phase Holographic Imaging PHI AB Announces Intent to File for Bankruptcy 12 January 2026 PHI Interim Report 2 2025/26 19 December 2025 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 OptiCell Solutions OptiCell Solutions enters into new collaboration 2 December 2025 ATMP Flemingsberg OptiCell Solutions enters a research collaboration with Karolinska Institutet 11 November 2025 DBMD Välkommen att ansöka till familjevistelsen om Duchennes muskeldystrofi! 5 November 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024
ATMP Sweden 2026

ATMP Sweden 2026

The premiere national meetup for the Swedish ATMP ecosystem is coming to Campus Flemingsberg in Stockholm, December 2026.

Read more
ATMP Sweden Webinars

ATMP Sweden Webinars

Join to learn from experts, patient advocates, and rising stars within ATMPs:

Read more

Events

The ATMP Mini-Symposium returns for its third edition on 19 May 2026 in Lund, bringing together academia, healthcare and industry for an open forum on ATMPs, spanning early research to clinical and industrial application. and collaboration.

20 May 2026 Conference & Congress

Droplet Digital™ PCR World 2026 User Meeting

ddPCR World On Tour is coming to Sweden in 2026, bringing the digital PCR community together for a user meeting focused on science, peer exchange, and applied insights.

20 May 2026 Networking

GoCo Open House 2026 

GoCo Health Innovation City, Sweden GoCo Health Innovation City

Step inside GoCo Health Innovation City during Open House 2026 – a day to explore innovations, meet the community and experience the ideas shaping the future of health and life science.

20 May 2026 Networking

Clinical Trials Day 2026

On 20 May 2026, Akademiska University Hospital invites researchers, healthcare professionals, patients and life science partners to celebrate Clinical Trials Day under the theme “How Research Becomes Care.”

News

2026-04-23 Jobs, Careers & Opportunities

Join the ESGCT ECR Board – Apply by 15 May 2026

Join the ESGCT ECR Board – Apply by 15 May 2026

The European Society of Gene and Cell Therapy is looking for its next ECR Board Member. Are you a PhD student or post-doc in gene and cell therapy? Applications close 15 May 2026.

Doctoral Course: From Research to ATMP Treatment
Flemingsberg Science Foundation natasha.bank@flemingsbergscience.se

Doctoral Course: From Research to ATMP Treatment

BioLamina secures €20M to scale cell therapy tech

EIB backs Swedish biotech scale-up BioLamina with €20 million to enable stem cell technologies targeting diseases such as type 1 diabetes, Parkinson’s disease, and heart failure

Doctoral course: From Research to ATMP Treatment 
Karolinska Institutet Original source

Karolinska Institutet offers a two-week doctoral course designed to provide a comprehensive overview of the entire process involved in developing and producing cell and gene therapy products.

Towards a Swedish Centre of Excellence in Bioanalytics: Introducing BACE

Sweden is strengthening its position in advanced bioanalytics with the launch of the BioAnalytical Cluster of Excellence (BACE), supported by Vinnova.

2026-03-02 Events & Conferences

ATMP Manufacturing Course – April 2026

ATMP Manufacturing Course – April 2026

Want to strengthen your expertise in hospital-based ATMP and cell therapy manufacturing? This three-day course in April 2026 offers practical insight into regulation, quality systems and clinical application.

Commercial Aspects of ATMPs
Commercial aspects of ATMPs

Learn more about the Health Technology Assessment related issues of your ATMP development.

ATMP Process Map
ATMP Process Map

Support in navigating ATMP development needs prompting the right competence, need, and time.

Job Board
Job Board

Find or advertise ATMP relevant job opportunities.

Newsletter
Newsletter

The ATMP Sweden newsletter provides updates on Swedish ATMP- and association developments.